Cargando…
Pharmacogenetics in the Brazilian Population
Brazil is the fifth largest country in the world and its present population, in excess of 190;million, is highly heterogeneous, as a result of centuries of admixture between Amerindians, Europeans, and Sub-Saharan Africans. The estimated individual proportions of biogeographical ancestry vary widely...
Autor principal: | Suarez-Kurtz, Guilherme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153000/ https://www.ncbi.nlm.nih.gov/pubmed/21833165 http://dx.doi.org/10.3389/fphar.2010.00118 |
Ejemplares similares
-
Pharmacogenetic testing in oncology: a Brazilian perspective
por: Suarez-Kurtz, Guilherme
Publicado: (2018) -
Pharmacogenomic implications of the differential distribution of CYP2C9 metabolic phenotypes among Latin American populations
por: Suarez-Kurtz, Guilherme
Publicado: (2023) -
Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin
por: Suarez-Kurtz, Guilherme, et al.
Publicado: (2012) -
Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients
por: Suarez-Kurtz, Guilherme, et al.
Publicado: (2023) -
Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data
por: Bertholim-Nasciben, Luciana, et al.
Publicado: (2023)